ArticleOncogene2025

A novel FAP-targeting antibody-exatecan conjugate improves immune checkpoint blockade by reversing immunosuppressive microenvironment in pancreatic cancer.

Xiaobao Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.